AI assistant
Ventripoint Diagnostics Ltd. — Regulatory Filings 2021
Oct 1, 2021
45675_rns_2021-10-01_0fbbf25e-0899-4248-92d1-a3aecc9482d2.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
FORM 51-102F3 MATERIAL CHANGE REPORT
1. Name and Address of Company
Ventripoint Diagnostics Ltd. (the " Company ") 2 Sheppard Ave. E. Suite 605 Toronto, ON M2N 5Y7
2. Date of Material Change
September 27, 2021.
3. News Release
On September 27, 2021, a news release was issued and disseminated through the facilities of a recognized newswire service.
4. Summary of Material Change
The material change is fully described in the Company’s press release which is attached as Schedule “A” and is incorporated herein.
5. Full Description of Material Change
A description of the material change is contained under Item 4.
6. Reliance on subsection 7.1(2) of National Instrument 51-102
The report is not being filed in reliance on section 7.1(2) of National Instrument 51-102.
7. Omitted Information
No information has been omitted.
8. Executive Officer
The name of the executive officer of the Company who is knowledgeable about the material change and this report is:
Dr. George Adams, Chief Executive Officer Tel: (519) 803-6937 Email: [email protected]
9. Date of Report
September 28, 2021.
SCHEDULE “A”
PRESS RELEASE
==> picture [494 x 664] intentionally omitted <==
==> picture [498 x 396] intentionally omitted <==